Quick Answer
Mct Oil Cognition Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: EK supplementation was associated with a statistically significant improvement in cognitive performance compared with placebo (SMD = 0.29, 95% CI 0.16-0.41; p p = 0.083), study duration (acute vs.
Key Takeaways
- 01EK supplementation was associated with a statistically significant improvement in cognitive performance compared with placebo (SMD = 0.29, 95% CI 0.16-0.41; p p = 0.083), study duration (acute vs. [Bonnechère B (2026)]
- 02Discussion EK supplementation is associated with modest improvements in cognitive performance across diverse populations and study designs. [Bonnechère B (2026)]
- 03Introduction Cognitive function is closely linked to brain energy metabolism and may be compromised by aging, metabolic stress, and neuropsychiatric disease. [Bonnechère B (2026)]
- 04Ketone bodies can serve as an alternative cerebral fuel and may also exert signaling effects relevant to cognition. [Bonnechère B (2026)]
The current Migaku evidence database contains 2 reusable source documents for Mct Oil Cognition Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove.
- EK supplementation was associated with a statistically significant improvement in cognitive performance compared with placebo (SMD = 0.29, 95% CI 0.16-0.41; p p = 0.083), study duration (acute vs. [Bonnechère B (2026); evidence level 1]
- Discussion EK supplementation is associated with modest improvements in cognitive performance across diverse populations and study designs. [Bonnechère B (2026); evidence level 1]
- Introduction Cognitive function is closely linked to brain energy metabolism and may be compromised by aging, metabolic stress, and neuropsychiatric disease. [Bonnechère B (2026); evidence level 1]
- Ketone bodies can serve as an alternative cerebral fuel and may also exert signaling effects relevant to cognition. [Bonnechère B (2026); evidence level 1]
- Background and objectives Postprandial hyperglycemia is a modifiable determinant of type 2 diabetes risk and vascular complications. [Kodama K (2026); evidence level 4]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources